These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26889145)

  • 1. Arterial Therapies of Non-Colorectal Liver Metastases.
    Puippe G; Pfammatter T; Schaefer N
    Viszeralmedizin; 2015 Dec; 31(6):414-22. PubMed ID: 26889145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Effective Are Percutaneous Liver-Directed Therapies in Patients with Non-Colorectal Liver Metastases?
    Vogl TJ; Emam A; Naguib NN; Eichler K; Zangos S
    Viszeralmedizin; 2015 Dec; 31(6):406-13. PubMed ID: 26889144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases.
    Swierz MJ; Storman D; Riemsma RP; Wolff R; Mitus JW; Pedziwiatr M; Kleijnen J; Bala MM
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009498. PubMed ID: 32163181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trials.
    Katsanos K; Kitrou P; Spiliopoulos S; Maroulis I; Petsas T; Karnabatidis D
    PLoS One; 2017; 12(9):e0184597. PubMed ID: 28934265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transarterial Chemoembolization vs Radioembolization for Neuroendocrine Liver Metastases: A Multi-Institutional Analysis.
    Egger ME; Armstrong E; Martin RC; Scoggins CR; Philips P; Shah M; Konda B; Dillhoff M; Pawlik TM; Cloyd JM
    J Am Coll Surg; 2020 Apr; 230(4):363-370. PubMed ID: 32032719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of hepatic intra-arterial therapies in metastatic neuroendocrine tumours (NET): guidelines from the NET-Liver-Metastases Consensus Conference.
    Kennedy A; Bester L; Salem R; Sharma RA; Parks RW; Ruszniewski P;
    HPB (Oxford); 2015 Jan; 17(1):29-37. PubMed ID: 25186181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arterial therapies of non-colorectal cancer metastases to the liver (from chemoembolization to radioembolization).
    Hoffmann RT; Paprottka P; Jakobs TF; Trumm CG; Reiser MF
    Abdom Imaging; 2011 Dec; 36(6):671-6. PubMed ID: 21584635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoembolization Versus Radioembolization for Neuroendocrine Liver Metastases: A Meta-analysis Comparing Clinical Outcomes.
    Ngo L; Elnahla A; Attia AS; Hussein M; Toraih EA; Kandil E; Killackey M
    Ann Surg Oncol; 2021 Apr; 28(4):1950-1958. PubMed ID: 33393019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transarterial therapies in patients with hepatocellular carcinoma eligible for transarterial embolization: a US cost-effectiveness analysis.
    Patel MV; Davies H; Williams AO; Bromilow T; Baker H; Mealing S; Holmes H; Anderson N; Ahmed O
    J Med Econ; 2023; 26(1):1061-1071. PubMed ID: 37632520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arterial therapies of colorectal cancer metastases to the liver.
    de Baere T; Deschamps F
    Abdom Imaging; 2011 Dec; 36(6):661-70. PubMed ID: 21681492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-arterial liver-directed therapies for neuroendocrine hepatic metastases.
    Gupta S
    Semin Intervent Radiol; 2013 Mar; 30(1):28-38. PubMed ID: 24436515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparison of the Outcomes of Transarterial Chemoembolization and Transarterial Radioembolization in the Management of Neuroendocrine Liver Metastases in Adults: A Systematic Review.
    Victory Srinivasan N; Venugopal S
    Cureus; 2023 Jun; 15(6):e40592. PubMed ID: 37469827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioembolization and chemoembolization for unresectable neuroendocrine liver metastases - a systematic review.
    Yang TX; Chua TC; Morris DL
    Surg Oncol; 2012 Dec; 21(4):299-308. PubMed ID: 22846894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter embolization therapy in liver cancer: an update of clinical evidences.
    Wáng YX; De Baere T; Idée JM; Ballet S
    Chin J Cancer Res; 2015 Apr; 27(2):96-121. PubMed ID: 25937772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Evolving Role of Radioembolization in the Treatment of Neuroendocrine Liver Metastases.
    Ramdhani K; Braat AJAT
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GEP-NETS update: Interventional radiology: role in the treatment of liver metastases from GEP-NETs.
    de Baere T; Deschamps F; Tselikas L; Ducreux M; Planchard D; Pearson E; Berdelou A; Leboulleux S; Elias D; Baudin E
    Eur J Endocrinol; 2015 Apr; 172(4):R151-66. PubMed ID: 25385817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver.
    Ruutiainen AT; Soulen MC; Tuite CM; Clark TW; Mondschein JI; Stavropoulos SW; Trerotola SO
    J Vasc Interv Radiol; 2007 Jul; 18(7):847-55. PubMed ID: 17609443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional Therapies for Colorectal Liver Metastases: Systematic Review and Clinical Practice Guideline.
    Karanicolas P; Beecroft JR; Cosby R; David E; Kalyvas M; Kennedy E; Sapisochin G; Wong R; Zbuk K;
    Clin Colorectal Cancer; 2021 Mar; 20(1):20-28. PubMed ID: 33257278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoembolization Beyond Hepatocellular Carcinoma: What Tumors Can We Treat and When?
    DePietro DM; Li X; Shamimi-Noori SM
    Semin Intervent Radiol; 2024 Feb; 41(1):27-47. PubMed ID: 38495263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.